The mitochondrial genome: A biosensor for early cancer detection?

Expert Opinion on Medical Diagnostics

Volumn 1, Issue 2, 2007, Pages 169-182

  Parr, Ryan L ^a   Jakupciak, John P ^b   Birch Machin, Mark A ^c   Dakubo, Gabriel D ^a  

^a Genesis Genomics   (Canada)

^b NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

biomarkers; cancer; mitochondrial DNA

Indexed keywords

EID: 80052133182     PISSN: 17530059     EISSN: 17530067     Source Type: Journal    
DOI: 10.1517/17530059.1.2.169     Document Type: Review

References (115)

1. POLYAK K, LI Y, ZHU H et al. : Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat. Genet. (1998) 20 (3): 291-293. (Pubitemid 28507677)
2. WARBURG O: On the origin of cancer cells. Science (1956) 123 (3191): 309-314.
3. LU F: Reactive oxygen species in cancer, too much or too little? Med. Hypotheses (2007) (In Press).
4. PETROS JA, BAUMANN AK, RUIZ-PESINI E et al. : mtDNA mutations increase tumorigenicity in prostate cancer. Proc. Natl. Acad. Sci. USA (2005) 102 (3): 719-724. (Pubitemid 40282732)
5. DAKUBO GD, JAKUPCIAK JP, BIRCH-MACHIN MA, PARR RL: Clinical implications and utility of field cancerization. Cancer Cell Int. (2007) 7 : 2 .
6. JONES JB, SONG JJ, HEMPEN PM, PARMIGIANI G, HRUBAN RH, KERN SE: Detection of mitochondrial DNA mutations in pancreatic cancer offers a mass -ive advantage over detection of nuclear DNA mutations. Cancer Res. (2001) 61 (4): 1299-1304. (Pubitemid 34292546)
7. PARR RL, MAKI J, REGULY B et al. : The pseudo-mitochondrial genome Influences mistakes in heteroplasmy interpretation. BMC Genomics (2006) 7 : 185 .
8. PARFAIT B, RUSTIN P, MUNNICH A, ROTIG A: Co-amplification of nuclear pseudogenes and assessment of heteroplasmy of mitochondrial DNA mutations. Biochem. Biophys. Res. Commun. (1998) 247 (1): 57-59. (Pubitemid 28412524)
9. JAKUPCIAK JP, WANG W, MARKOWITZ ME et al. : Mitochondrial DNA as a cancer biomarker. J. Mol. Diagn. (2005) 7 (2): 258-267. (Pubitemid 40668309)
10. ANDERSON S, BANKIER AT, BARRELL BG et al. : Sequence and organization of the human mitochondrial genome. Nature (1981) 290 (5806): 457-465. (Pubitemid 11159074)
11. SALAS A, YAO YG, MACAULAY V, VEGA A, CARRACEDO A, BANDELT HJ: A critical reassessment of the role of mitochondria in tumorigenesis. PLoS Med. (2005) 2 (11): E296 .
12. ZANSSEN S, SCHON EA: Mitochondrial DNA mutations in cancer. PLoS Med. (2005) 2 (11): E401 .
13. GUO XG, GUO QN: Mutations in the mitochondrial DNA D-Loop region occur frequently in human osteosarcoma. Cancer Lett. (2006) 239 (1): 151-155.
14. LIANG BC: Evidence for association of mitochondrial DNA sequence amplification and nuclear localization in human low-grade gliomas. Mutat. Res. (1996) 354 (1): 27-33. (Pubitemid 26238526)
15. KIRCHES E, KRAUSE G, WARICH-KIRCHES M et al. : High frequency of mitochondrial DNA mutations in glioblastoma multiforme identifi ed by direct sequence comparison to blood samples. Int. J. Cancer (2001) 93 (4): 534-538. (Pubitemid 32701412)
16. MONTANINI L, REGNA-GLADIN C, EOLI M et al. : Instability of mitochondrial DNA and MRI and clinical correlations in malignant gliomas. J. Neurooncol. (2005) 74 (1): 87-89. (Pubitemid 41194536)
17. WONG LJ, LUETH M, LI XN, LAU CC, VOGEL H: Detection of mitochondrial DNA mutations in the tumor and cerebrospinal fluid of medulloblastoma patients. Cancer Res. (2003) 63 (14): 3866-3871. (Pubitemid 36917895)
18. TAN DJ, BAI RK, WONG LJ: Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res. (2002) 62 (4): 972-976.
19. PARRELLA P, XIAO Y, FLISS M et al. : Detection of mitochondrial DNA mutations in primary breast cancer and fi ne-needle aspirates. Cancer Res. (2001) 61 (20): 7623-7626. (Pubitemid 32995057)
20. ROSSON D, KESHGEGIAN AA: Frequent mutations in the mitochondrial control region DNA in breast tissue. Cancer Lett. (2004) 215 (1): 89-94. (Pubitemid 39221463)
21. BRANDON MC, LOTT MT, NGUYEN KC et al.: MITOMAP: a human mitochondrial genome database - 2004 update. Nucleic Acids Res. (2005) 33 (Database Issue): D611-D613. (Pubitemid 40207946)
22. TSENG LM, YIN PH, CHI CW et al. : Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer. Genes Chromosomes Cancer (2006) 45 (7): 629-638.
23. PARR RL, DAKUBO GD, CRANDALL KA et al. : Somatic mitochondrial DNA mutations in prostate cancer and normal appearing adjacent glands in comparison to age-matched prostate samples without malignant histology. J. Mol. Diagn. (2006) 8 (3): 312-319. (Pubitemid 44063807)
24. DANI MA, DANI SU, LIMA SP et al. : Less DeltamtDNA4977 than normal in various types of tumors suggests that cancer cells are essentially free of this mutation. Genet. Mol. Res. (2004) 3 (3): 395-409.
25. MAMBO E, CHATTERJEE A, XING M et al. : Tumor-specific changes in mtDNA content in human cancer. Int. J. Cancer (2005) 116 (6): 920-924. (Pubitemid 41209199)
26. WANG Y, LIU VW, TSANG PC et al. : Microsatellite instability in mitochondrial genome of common female cancers. Int. J. Gynecol. Cancer (2006) 16 (Suppl. 1): 259-266.
27. RICHARD SM, BAILLIET G, PAEZ GL, BIANCHI MS, PELTOMAKI P, BIANCHI NO: Nuclear and mitochondrial genome instability in human breast cancer. Cancer Res. (2000) 60 (15): 4231-4237. (Pubitemid 30636610)
28. ZHU W, QIN W, BRADLEY P, WESSEL A, PUCKETT CL, SAUTER ER: Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid. Carcinogenesis (2005) 26 (1): 145-152. (Pubitemid 40207709)
29. SHARMA H, SINGH A, SHARMA C, JAIN SK, SINGH N: Mutations in the mitochondrial DNA D-loop region are frequent in cervical cancer. Cancer Cell Int. (2005) 5 : 34 .
30. ALLALUNIS-TURNER J, MA I, HANSON J, PEARCEY RG: mtDNA mutations in invasive cervix tumors: a retrospective analysis. Cancer Lett. (2006) 243 (2): 193-201. (Pubitemid 44485855)
31. ALONSO A, MARTIN P, ALBARRAN C et al. : Detection of somatic mutations in the mitochondrial DNA control region of colorectal and gastric tumors by heteroduplex and single-strand conformation analysis. Electrophoresis (1997) 18 (5): 682-685. (Pubitemid 27226964)
32. HABANO W, SUGAI T, YOSHIDA T, NAKAMURA S: Mitochondrial gene mutation, but not large-scale deletion, is a feature of colorectal carcinomas with mitochondrial microsatellite instability. Int. J. Cancer (1999) 83 (5): 625-629. (Pubitemid 29508041)
33. HABANO W, NAKAMURA S, SUGAI T: Microsatellite instability in the mitochondrial DNA of colorectal carcinomas: evidence for mismatch repair systems in mitochondrial genome. Oncogene (1998) 17 (15): 1931-1937. (Pubitemid 28488461)
34. AIKHIONBARE FO, KHAN M, CAREY D, OKOLI J, GO R: Is cumulative frequency of mitochondrial DNA variants a biomarker for colorectal tumor progression? Mol. Cancer (2004) 3 : 30 .
35. LIEVRE A, CHAPUSOT C, BOUVIER AM et al. : Clinical value of mitochondrial mutations in colorectal cancer. J. Clin. Oncol. (2005) 23 (15): 3517-3525.
36. GULENG G, LOVIG T, MELING GI, ANDERSEN SN, ROGNUM TO: Mitochondrial microsatellite instability in colorectal carcinomas-frequency and association with nuclear microsatellite instability. Cancer Lett. (2005) 219 (1): 97-103. (Pubitemid 40203176)
37. KOSE K, HIYAMA T, TANAKA S, YOSHIHARA M, YASUI W, CHAYAMA K: Somatic mutations of mitochondrial DNA in digestive tract cancers. J. Gastroenterol. Hepatol. (2005) 20 (11): 1679-1684. (Pubitemid 43961072)
38. KIM HS, LIM HS, LEE SH et al. : Mitochondrial microsatellite instability of colorectal cancer stroma. Int. J. Cancer (2006) 119 (11): 2607-2611. (Pubitemid 44691315)
39. LIU VW, YANG HJ, WANG Y et al. : High frequency of mitochondrial genome instability in human endometrial carcinomas. Br. J. Cancer (2003) 89 (4): 697-701. (Pubitemid 37076176)
40. WANG Y, XUE WC, LIU VW, NGAN HY: Detection of mosaic pattern of mitochondrial DNA alterations in different populations of cells from the same endometrial tumor. Mitochondrion (2007) 7 (1-2): 171-175. (Pubitemid 46351967)
41. SEMCZUK A, LORENC A, PUTOWSKI L et al. : Clinicoprognostical features of endometrial cancer patients with somatic mtDNA mutations. Oncol. Rep. (2006) 16 (5): 1041-1045.
42. PEJOVIC T, LADNER D, INTENGAN M et al. : Somatic D-loop mitochondrial DNA mutations are frequent in uterine serous carcinoma. Eur. J. Cancer (2004) 40 (16): 2519-2524. (Pubitemid 39424969)
43. HIBI K, NAKAYAMA H, YAMAZAKI T et al. : Mitochondrial DNA alteration in esophageal cancer. Int. J. Cancer (2001) 92 (3): 319-321. (Pubitemid 32249704)
44. KUMIMOTO H, YAMANE Y, NISHIMOTO Y et al. : Frequent somatic mutations of mitochondrial DNA in esophageal squamous cell carcinoma. Int. J. Cancer (2004) 108 (2): 228-231. (Pubitemid 37541775)
45. ABNET CC, HUPPI K, CARRERA A et al. : Control region mutations and the common deletion are frequent in the mitochondrial DNA of patients with esophageal squamous cell carcinoma. BMC Cancer (2004) 4 : 30 .
46. MIYAZONO F, SCHNEIDER PM, METZGER R et al. : Mutations in the mitochondrial DNA D-Loop region occur frequently in adenocarcinoma in Barrett s esophagus. Oncogene (2002) 21 (23): 3780-3783. (Pubitemid 34620540)
47. HABANO W, SUGAI T, NAKAMURA SI, UESUGI N, YOSHIDA T, SASOU S: Microsatellite instability and mutation of mitochondrial and nuclear DNA in gastric carcinoma. Gastroenterology (2000) 118 (5): 835-841. (Pubitemid 30243746)
48. MAXIMO V, SOARES P, SERUCA R, ROCHA AS, CASTRO P, SOBRINHO-SIMOES M: Microsatellite instability, mitochondrial DNA large deletions, and mitochondrial DNA mutations in gastric carcinoma. Genes Chromosomes Cancer (2001) 32 (2): 136-143.
49. MAXIMO V, SOARES P, SERUCA R, SOBRINHO-SIMOES M: Comments on: mutations in mitochondrial control region DNA in gastric tumours of Japanese patients. Eur. J. Cancer (1999) 35 (9): 1407-1408. (Pubitemid 29397444)
50. ZHAO YB, YANG HY, ZHANG XW, CHEN GY: Mutation in D-loop region of mitochondrial DNA in gastric cancer and its significance. World J. Gastroenterol. (2005) 11 (21): 3304-3306.
51. WU CW, YIN PH, HUNG WY et al. : Mitochondrial DNA mutations and mitochondrial DNA depletion in gastric cancer. Genes Chromosomes Cancer (2005) 44 (1): 19-28.
52. KAMALIDEHGHAN B, HOUSHMAND M, ISMAIL P, PANAHI MS, AKBARI MH: Delta mtDNA4977 is more common in non-tumoral cells from gastric cancer sample. Arch. Med. Res. (2006) 37 (6): 730-735. (Pubitemid 43975173)
53. KAMALIDEHGHAN B, HOUSHMAND M, PANAHI MS, ABBASZADEGAN MR, ISMAIL P, SHIROUDI MB: Tumoral cell mtDNA approximately 8.9 kb deletion is more common than other deletions in gastric cancer. Arch. Med. Res. (2006) 37 (7): 848-853. (Pubitemid 44333144)
54. HA PK, TONG BC, WESTRA WH et al. : Mitochondrial C-tract alteration in premalignant lesions of the head and neck: a marker for progression and clonal proliferation. Clin. Cancer Res. (2002) 8 (7): 2260-2265. (Pubitemid 34753599)
55. LIEVRE A, BLONS H, HOULLIER AM et al. : Clinicopathological significance of mitochondrial D-Loop mutations in head and neck carcinoma. Br. J. Cancer (2006) 94 (5): 692-697. (Pubitemid 43361901)
56. PRIOR SL, GRIFFITHS AP, BAXTER JM et al. : Mitochondrial DNA mutations in oral squamous cell carcinoma. Carcinogenesis (2006) 27 (5): 945-950.
57. POETSCH M, PETERSMANN A, LIGNITZ E, KLEIST B: Relationship between mitochondrial DNA instability, mitochondrial DNA large deletions, and nuclear microsatellite instability in head and neck squamous cell carcinomas. Diagn. Mol. Pathol. (2004) 13 (1): 26-32. (Pubitemid 38263880)
58. SHAO JY, LI YH, GAO HY et al. : High frequency of common deletion (4981 bp) in mitochondrial DNA in nasopharyngeal carcinoma and its correlation with patient age and clinical stages. Cancer Biol. Ther. (2004) 3 (12): 1270-1274.
59. HAN YC, KONG WJ, ZHANG S, WANG YJ, WANG Y, CHEN X: Mutation of mitochondrial DNA 4977 bp deletion in laryngeal squamous cell cancer. Ai Zheng (2004) 23 (11): 1297-1301.
60. SHIEH DB, CHOU WP, WEI YH, WONG TY, JIN YT: Mitochondrial DNA 4,977-bp deletion in paired oral cancer and precancerous lesions revealed by laser microdissection and real-time quantitative PCR. Ann. NY Acad. Sci. (2004) 1011 : 154-167.
61. ZHOU S, KACHHAP S, SUN W et al. : Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck. Proc. Natl. Acad. Sci. USA (2007) 104 (18): 7540-7545. (Pubitemid 47185942)
62. JIANG WW, MASAYESVA B, ZAHURAK M et al. : Increased mitochondrial DNA content in saliva associated with head and neck cancer. Clin. Cancer Res. (2005) 11 (7): 2486-2491. (Pubitemid 40569444)
63. KIM MM, CLINGER JD, MASAYESVA BG et al. : Mitochondrial DNA quantity increases with histopathologic grade in premalignant and malignant head and neck lesions. Clin. Cancer Res. (2004) 10 (24): 8512-8515. (Pubitemid 40053417)
64. SHAO JY, GAO HY, LI YH, ZHANG Y, LU YY, ZENG YX: Quantitative detection of common deletion of mitochondrial DNA in hepatocellular carcinoma and hepatocellular nodular hyperplasia. World J. Gastroenterol. (2004) 10 (11): 1560-1564. (Pubitemid 38786931)
65. NISHIKAWA M, NISHIGUCHI S, SHIOMI S et al. : Somatic mutation of mitochondrial DNA in cancerous and noncancerous liver tissue in individuals with hepatocellular carcinoma. Cancer Res. (2001) 61 (5): 1843-1845. (Pubitemid 32691996)
66. NOMOTO S, YAMASHITA K, KOSHIKAWA K, NAKAO A, SIDRANSKY D: Mitochondrial D-loop mutations as clonal markers in multicentric hepatocellular carcinoma and plasma. Clin. Cancer Res. (2002) 8 (2): 481-487. (Pubitemid 34193968)
67. LEE HC, LI SH, LIN JC, WU CC, YEH DC, WEI YH: Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma. Mutat. Res. (2004) 547 (1-2): 71-78.
68. TAMORI A, NISHIGUCHI S, NISHIKAWA M et al. : Correlation between clinical characteristics and mitochondrial D-loop DNA mutations in hepatocellular carcinoma. J. Gastroenterol. (2004) 39 (11): 1063-1068. (Pubitemid 39618789)
69. YIN PH, LEE HC, CHAU GY et al. : Alteration of the copy number and deletion of mitochondrial DNA in human hepatocellular carcinoma. Br. J. Cancer (2004) 90 (12): 2390-2396. (Pubitemid 38961905)
70. YAMADA S, NOMOTO S, FUJII T et al. : Correlation between copy number of mitochondrial DNA and clinico-pathologic parameters of hepatocellular carcinoma. Eur. J. Surg. Oncol. (2006) 32 (3): 303-307.
71. SUZUKI M, TOYOOKA S, MIYAJIMA K et al. : Alterations in the mitochondrial displacement loop in lung cancers. Clin. Cancer Res. (2003) 9 (15): 5636-5641. (Pubitemid 37499485)
72. MATSUYAMA W, NAKAGAWA M, WAKIMOTO J, HIROTSU Y, KAWABATA M, OSAME M: Mitochondrial DNA mutation correlates with stage progression and prognosis in non-small cell lung cancer. Hum. Mutat. (2003) 21 (4): 441-443. (Pubitemid 36389833)
73. MORANDI L, ASIOLI S, CAVAZZA A, PESSION A, DAMIANI S: Genetic relationship among atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and adenocarcinoma of the lung. Lung Cancer (2007) 56 (1): 35-42. (Pubitemid 46356643)
74. DAI JG, XIAO YB, MIN JX, ZHANG GQ, YAO K, ZHOU RJ: Mitochondrial DNA 4977 BP deletion mutations in lung carcinoma. Indian J. Cancer (2006) 43 (1): 20-25. (Pubitemid 43900538)
75. LIU VW, SHI HH, CHEUNG AN et al. : High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Res. (2001) 61 (16): 5998-6001. (Pubitemid 32762527)
76. AIKHIONBARE FO, MEHRABI S, KUMARESAN K et al. : Mitochondrial DNA sequence variants in epithelial ovarian tumor subtypes and stages. J. Carcinog. (2007) 6 : 1 .
77. VAN TRAPPEN PO, CULLUP T, TROKE R et al. : Somatic mitochondrial DNA mutations in primary and metastatic ovarian cancer. Gynecol. Oncol. (2007) 104 (1): 129-133. (Pubitemid 46075144)
78. NAVAGLIA F, BASSO D, FOGAR P et al. : Mitochondrial DNA D-loop in pancreatic cancer: somatic mutations are epiphenomena while the germline 16519 T variant worsens metabolism and outcome. Am. J. Clin. Pathol. (2006) 126 (4): 593-601. (Pubitemid 44498510)
79. MU DQ, GAO LJ, PENG SY, LI JT: Significance of the mitochondrial D-loop alterations in hyperplastic pancreatic ductal cells in the vicinity of pancreatic cancer coexisting with chronic pancreatitis. Zhonghua Zhong Liu Za Zhi (2006) 28 (6): 433-437.
80. CHEN JZ, GOKDEN N, GREENE GF, GREEN B, KADLUBAR FF: Simultaneous generation of multiple mitochondrial DNA mutations in human prostate tumors suggests mitochondrial hyper-mutagenesis. Carcinogenesis (2003) 24 (9): 1481-1487. (Pubitemid 37160838)
81. COSTELLO LC, FRANKLIN RB: The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. Mol. Cancer (2006) 5 : 17 .
82. DAKUBO GD, PARR RL, COSTELLO LC, FRANKLIN RB, THAYER RE: Altered metabolism and mitochondrial genome in prostate cancer. J. Clin. Pathol. (2006) 59 (1): 10-16. (Pubitemid 43076233)
83. JERONIMO C, NOMOTO S, CABALLERO OL et al. : Mitochondrial mutations in early stage prostate cancer and bodily fluids. Oncogene (2001) 20 (37): 5195-5198. (Pubitemid 32844048)
84. CHEN JZ, GOKDEN N, GREENE GF, MUKUNYADZI P, KADLUBAR FF: Extensive somatic mitochondrial mutations in primary prostate cancer using laser capture microdissection. Cancer Res. (2002) 62 (22): 6470-6474. (Pubitemid 35364109)
85. GOMEZ-ZAERA M, ABRIL J, GONZALEZ L et al. : Identification of somatic and germline mitochondrial DNA sequence variants in prostate cancer patients. Mutat. Res. (2006) 595 (1-2): 42-51. (Pubitemid 43277848)
86. JESSIE BC, SUN CQ, IRONS HR, MARSHALL FF, WALLACE DC, PETROS JA: Accumulation of mitochondrial DNA deletions in the malignant prostate of patients of different ages. Exp. Gerontol. (2001) 37 (1): 169-174. (Pubitemid 33152708)
87. HIGUCHI M, KUDO T, SUZUKI S et al. : Mitochondrial DNA determines androgen dependence in prostate cancer cell lines. Oncogene (2006) 25 (10): 1437-1445. (Pubitemid 43361929)
88. MAKI JKR, REGULY B, ALEXANDER J et al. : Mitochondrial genome deletion aids in the Identification of both false and true negative prostate needle core biopsies. Am. J. Clin. Pathol. (2007) (In Press).
89. MEIERHOFER D, MAYR JA, FINK K, SCHMELLER N, KOFLER B, SPERL W: Mitochondrial DNA mutations in renal cell carcinomas revealed no general impact on energy metabolism. Br. J. Cancer (2006) 94 (2): 268-274. (Pubitemid 43151546)
90. WADA T, TANJI N, OZAWA A et al. : Mitochondrial DNA mutations and 8-hydroxy-2-deoxyguanosine content in Japanese patients with urinary bladder and renal cancers. Anticancer Res. (2006) 26 (5A): 3403-3408. (Pubitemid 44701515)
91. NAGY A, WILHELM M, SUKOSD F, LJUNGBERG B, KOVACS G: Somatic mitochondrial DNA mutations in human chromophobe renal cell carcinomas. Genes Chromosomes Cancer (2002) 35 (3): 256-260.
92. NAGY A, WILHELM M, KOVACS G: Mutations of mtDNA in renal cell tumours arising in end-stage renal disease. J. Pathol. (2003) 199 (2): 237-242. (Pubitemid 36176030)
93. BIRCH-MACHIN MA: The role of mitochondria in ageing and carcinogenesis. Clin. Exp. Dermatol. (2006) 31 (4): 548-552. (Pubitemid 43806591)
94. PASSOS JF, SARETZKI G, AHMED S et al. : Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere-dependent senescence. PLoS Biol. (2007) 5 (5): E110 .
95. BIRKET MBMM: The T414G mitochondrial DNA point mutation accumulates in a photoaging-dependent manner in human skin. Ageing Cell (2007) 6(5):557-564.
96. DURHAM SE, KRISHNAN KJ, BETTS J, BIRCH-MACHIN MA: Mitochondrial DNA damage in non-melanoma skin cancer. Br. J. Cancer (2003) 88 (1): 90-95. (Pubitemid 36241223)
97. HARBOTTLE A, KRISHNAN KJ, BIRCH-MACHIN MA: Implications of using the ND1 gene as a control region for real-time PCR analysis of mitochondrial DNA deletions in human skin. J. Invest. Dermatol. (2004) 122 (6): 1518-1521. (Pubitemid 38757236)
98. HARBOTTLE A, BIRCH-MACHIN MA: Real-time PCR analysis of a 3895 bp mitochondrial DNA deletion in nonmelanoma skin cancer and its use as a quantitative marker for sunlight exposure in human skin. Br. J. Cancer (2006) 94 (12): 1887-1893. (Pubitemid 43882580)
99. KRISHNAN KJ, HARBOTTLE A, BIRCH-MACHIN MA: The use of a 3895 bp mitochondrial DNA deletion as a marker for sunlight exposure in human skin. J. Invest. Dermatol. (2004) 123 (6): 1020-1024. (Pubitemid 39586820)
100. DEICHMANN M, KAHLE B, BENNER A, THOME M, HELMKE B, NAHER H: Somatic mitochondrial mutations in melanoma resection specimens. Int. J. Oncol. (2004) 24 (1): 137-141.
101. POETSCH M, DITTBERNER T, PETERSMANN A, WOENCKHAUS C: Mitochondrial DNA instability in malignant melanoma of the skin is mostly restricted to nodular and metastatic stages. Melanoma Res. (2004) 14 (6): 501-508. (Pubitemid 40221141)
102. TAKEUCHI H, FUJIMOTO A, HOON DS: Detection of mitochondrial DNA alterations in plasma of malignant melanoma patients. Ann. NY Acad. Sci. (2004) 1022 : 50-54. (Pubitemid 38951581)
103. ESHAGHIAN A, VLEUGELS RA, CANTER JA, MCDONALD MA, STASKO T, SLIGH JE: Mitochondrial DNA deletions serve as biomarkers of aging in the skin, but are typically absent in nonmelanoma skin cancers. J. Invest. Dermatol. (2006) 126 (2): 336-344. (Pubitemid 43323168)
104. KAMENISCH Y, WENZ J, METZLER G et al. : The mitochondrial DNA common deletion is present in most basal and squamous cell carcinoma samples isolated by laser capture microdissection but generally at reduced rather than increased levels. J. Invest. Dermatol. (2007) 127 (2): 486-490. (Pubitemid 46106929)
105. YEH JJ, LUNETTA KL, VAN ORSOUW NJ et al. : Somatic mitochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential mtDNA sequence variants in cases with thyroid tumours. Oncogene (2000) 19 (16): 2060-2066. (Pubitemid 30229419)
106. TONG BC, HA PK, DHIR K et al. : Mitochondrial DNA alterations in thyroid cancer. J. Surg. Oncol. (2003) 82 (3): 170-173. (Pubitemid 36278264)
107. MAXIMO V, SOARES P, LIMA J, CAMESELLE-TEIJEIRO J, SOBRINHO-SIMOES M: Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hurthle cell tumors. Am. J. Pathol. (2002) 160 (5): 1857-1865. (Pubitemid 34525665)
108. MAXIMO V, LIMA J, SOARES P, BOTELHO T, GOMES L, SOBRINHO-SIMOES M: Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy. Mitochondrion (2005) 5 (5): 333-340. (Pubitemid 41435216)
109. WITTE J, LEHMANN S, WULFERT M, YANG Q, ROHER HD: Mitochondrial DNA mutations in differentiated thyroid cancer with respect to the age factor. World J. Surg. (2007) 31 (1): 51-59. (Pubitemid 46089543)
110. O SHAUGHNESSY JA, KELLOFF GJ, GORDON GB et al. : Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development. Clin. Cancer Res. (2002) 8 (2): 314-346.
111. BANDELT HJ, LAHERMO P, RICHARDS M, MACAULAY V: Detecting errors in mtDNA data by phylogenetic analysis. Int. J. Legal Med. (2001) 115 (2): 64-69. (Pubitemid 33009609)
112. BRANDON M, BALDI P, WALLACE DC: Mitochondrial mutations in cancer. Oncogene (2006) 25 (34): 4647-4662. (Pubitemid 44187615)
113. BENZER S: On the topography of the genetic fi ne structure. Proc. Natl. Acad. Sci. USA (1961) 47 (3): 403-415.
114. MAITRA A, COHEN Y, GILLESPIE SE et al. : The human MitoChip: a high-throughput sequencing microarray for mitochondrial mutation detection. Genome Res. (2004) 14 (5): 812-819. (Pubitemid 38660497)
115. MEIERHOFER D, MAYR JA, EBNER S, SPERL W, KOFLER B: Rapid screening of the entire mitochondrial DNA for low-level heteroplasmic mutations. Mitochondrion (2005) 5 (4): 282-296. (Pubitemid 41015415)